Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Oncolytics Biotech enters into agreement for phase II Reolysin study

May 7, 2012

Exelixis expands cabozantinib development program

May 7, 2012

Abbott to acquire melanocortin receptor agonist

May 7, 2012

Caisson Biotech forms licensing agreement with Novo Nordisk

May 4, 2012

Dako and Genentech to collaborate on U.S. regulatory submissions for companion diagnostics

May 3, 2012

Genomic Health and OncoMed form alliance

May 3, 2012

Quark to conduct phase IIa study of siRNA drug in open-angle glaucoma

May 3, 2012

Altor BioScience product to enter clinical testing for melanoma

May 3, 2012

Trevena enters collaboration to identify novel biased ligand molecules

May 3, 2012

AnaptysBio and Gilead Sciences sign antibody discovery partnership

May 2, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...